Literature DB >> 3879016

Comparison of immunomodulatory and immunotherapeutic properties of biologic response modifiers.

J E Talmadge, M A Chirigos.   

Abstract

Mesh:

Substances:

Year:  1985        PMID: 3879016     DOI: 10.1007/BF01857395

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN: 0344-4325


× No keyword cloud information.
  24 in total

Review 1.  The preclinical screening laboratory: evaluation of immunomodulatory and therapeutic properties of biological response modifiers.

Authors:  J E Talmadge; R B Herberman
Journal:  Cancer Treat Rep       Date:  1986-01

2.  Practical considerations for the establishment of a screening procedure for the assessment of biological response modifiers.

Authors:  J E Talmadge; R K Oldham; I J Fidler
Journal:  J Biol Response Mod       Date:  1984

Review 3.  Current NCI preclinical antitumor screening in vivo: results of tumor panel screening, 1976-1982, and future directions.

Authors:  J M Venditti; R A Wesley; J Plowman
Journal:  Adv Pharmacol Chemother       Date:  1984

4.  Activation of mouse macrophages by pyran copolymer and role in augmentation of natural killer activity.

Authors:  P Puccetti; A Santoni; C Riccardi; H T Holden; R B Herberman
Journal:  Int J Cancer       Date:  1979-12-15       Impact factor: 7.396

5.  Immunomodulatory effect of various molecular-weight maleic anhydride-divinyl ethers and other agents in vivo.

Authors:  M A Chirigos; W A Stylos
Journal:  Cancer Res       Date:  1980-06       Impact factor: 12.701

6.  Immunotherapy of Madison 109 lung carcinoma and other murine tumors using lentinan.

Authors:  W C Rose; F C Reed; P Siminoff; W T Bradner
Journal:  Cancer Res       Date:  1984-04       Impact factor: 12.701

7.  Antitumor activity of lentinan in murine syngeneic and autochthonous hosts and its suppressive effect on 3-methylcholanthrene-induced carcinogenesis.

Authors:  T Suga; T Shiio; Y Y Maeda; G Chihara
Journal:  Cancer Res       Date:  1984-11       Impact factor: 12.701

8.  Therapy of autochthonous skin cancers in mice with intravenously injected liposomes containing muramyltripeptide.

Authors:  J E Talmadge; B F Lenz; R Klabansky; R Simon; C Riggs; S Guo; R K Oldham; I J Fidler
Journal:  Cancer Res       Date:  1986-03       Impact factor: 12.701

9.  Immunomodulatory effects in mice of polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose.

Authors:  J E Talmadge; J Adams; H Phillips; M Collins; B Lenz; M Schneider; E Schlick; R Ruffmann; R H Wiltrout; M A Chirigos
Journal:  Cancer Res       Date:  1985-03       Impact factor: 12.701

10.  Immunoregulation and immunostimulation of murine lymphocytes by recombinant human interleukin-2.

Authors:  J E Talmadge
Journal:  J Biol Response Mod       Date:  1985-02
View more
  1 in total

1.  Synergism of synthetic acyltripeptide and its analogs with recombinant interferon gamma for activation of antitumor properties of human blood monocytes.

Authors:  S Sone; A Okubo; N Inamura; A Nii; T Ogura
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.